The Effect of Hypermobility Healthy Individuals

February 7, 2020 updated by: Gülşah Karaca, Istanbul Kültür University

The Effect of Hypermobility on Respiratory Functions in Musicians Playing Wind Instruments and Healthy Individuals Not Involved in Music

Benign Joint Hypermobility Syndrome is a hereditary connective tissue problem characterized by the emergence of multiple musculoskeletal problems in hypermobile individuals without a systemic rheumatologic disease. Studies have shown that hypermobility may also affect lung function. Playing wind instruments requires tiring breathing activity. The effect of wind instrument on lung function and how it affects lung function is a highly controversial issue. Given the distribution and importance of collagen tissue in the body, multiple effects of hypermobility are inevitable. The aim of this study was to evaluate the presence of hypermobility in young healthy individuals; The aim of the study is to investigate the effects of hypermobility on the cardiovascular system and to provide training to the participants regarding the findings.The aim of this study is to investigate the relationship of hypermobility with respiratory functions in professional hypermobile musicians and to compare this relationship with healthy hypermobile individuals who are not engaged in music.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Sociodemographic data and musical backgrounds of all cases will be recorded. In accordance with the objectives, erm Upper Extremity Hypermobility Assessment Questionnaire "was used for hypermobility, pulmonary function test, respiratory and oral pressure measurement and respiratory muscle strength. The George Respiratory Questionnaire (SGRQ) will be used to assess the quality of life associated with respiration and the risk of asthma with the ile European Respiratory Health Survey, Phase 1 "questionnaire.We believe that the effects of hypermobility on pulmonary functions in healthy individuals will be clarified if this study takes place.

Study Type

Observational

Enrollment (Anticipated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • E5 Highway Bakırköy, İstanbul
      • Istanbul, E5 Highway Bakırköy, İstanbul, Turkey, 34158
        • Recruiting
        • Istanbul Kültür University
        • Contact:
        • Principal Investigator:
          • Esra Pehlivan, Asst.Prof.Dr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The musicians who meet the criteria for inclusion in the study and who play the wind instrument who agree to voluntarily participate in the study and healthy individuals who are not interested in music will be included.

Description

Inclusion Criteria for Musicians

Be between 18-35 years Playing wind instruments for at least one year For the hypermobile subgroup; Obtaining ≥7 / 12 points from the Upper Extremity Hypermobility Assessment Questionnaire

Inclusion Criteria for Healthy Individuals Not Engaged in Music

Be between 18-35 years No diagnosed health problems For the hypermobile subgroup; Obtaining ≥7 / 12 points from the Upper Extremity Hypermobility Assessment Questionnaire

Exclusion Criteria for Musicians

Having a specific respiratory problem diagnosed Symptoms of nerve impingement in upper extremity Smoking

Exclusion Criteria for Healthy Individuals Not Engaged in Music

Symptoms of nerve impingement in upper extremity Smoking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy Musician
At least 15 hypermobile musicians and at least 15 non-hypermobile musicians will be included in the study.
Hypermobility and Respiratory evaluation
Healthy Individuals
The study will include at least 15 healthy non-hypermobile individuals who do not deal with music and at least 15 healthy hypermobile individuals who do not deal with music.
Hypermobility and Respiratory evaluation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Upper Limb Hypermobility Assessment Tool
Time Frame: 10 minutes
Hypermobility
10 minutes
St. George Respiratory Questionnaire
Time Frame: 5 minutes
respiratory quality
5 minutes
European Respiratory Health Survey, Phase 1
Time Frame: 5 minutes
assess the risk of asthma
5 minutes
Respiratory function test
Time Frame: 15minutes
FEV1,FVC
15minutes
mouth pressure measurement
Time Frame: 15minutes
MIP, MEP
15minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Musculoskeletal Pain Intensity and Interference Questionnaire for Musicians
Time Frame: 10 minutes
Pain
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Esra Pehlivan, Asst.Prof.Dr, Saglik Bilimleri Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2019

Primary Completion (ANTICIPATED)

December 30, 2020

Study Completion (ANTICIPATED)

December 30, 2020

Study Registration Dates

First Submitted

December 16, 2019

First Submitted That Met QC Criteria

December 18, 2019

First Posted (ACTUAL)

December 23, 2019

Study Record Updates

Last Update Posted (ACTUAL)

February 10, 2020

Last Update Submitted That Met QC Criteria

February 7, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • IstanbulKulturU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Problems

Clinical Trials on Respiratory evaluation

3
Subscribe